Related references
Note: Only part of the references are listed.Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells
Paul Loar et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer
S. Fogarty et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Too Much of a Good Thing: Suicide Prevention Promotes Chemoresistance in Ovarian Carcinoma
K. Pennington et al.
CURRENT CANCER DRUG TARGETS (2010)
Clinical relevance of extent of extreme drug resistance in epithelial ovarian carcinoma
Koji Matsuo et al.
GYNECOLOGIC ONCOLOGY (2010)
p53 Regulation of Metabolic Pathways
Eyal Gottlieb et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism
Divya Pathania et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Hexokinase II detachment from the mitochondria potentiates cisplatin induced cytotoxicity through a caspase-2 dependent mechanism
Nataly Shulga et al.
CELL CYCLE (2009)
The HIV protease inhibitor saquinavir induces endoplasmic reticulum stress, autophagy, and apoptosis in ovarian cancer cells
Karen McLean et al.
GYNECOLOGIC ONCOLOGY (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Glycolytic enzyme inhibitors in cancer treatment
Roberto Scatena et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance
R. Salani et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Glucose Metabolism Attenuates p53 and Puma-dependent Cell Death upon Growth Factor Deprivation
Yuxing Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance
Chun-Wun Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Causes and consequences of increased glucose metabolism of cancers
Robert J. Gillies et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth
Brian Clem et al.
MOLECULAR CANCER THERAPEUTICS (2008)
BCL-2 family antagonists for cancer therapy
Guillaume Lessene et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Mitochondria in cancer cells: what is so special about them?
Vladimir Gogvadze et al.
TRENDS IN CELL BIOLOGY (2008)
Mitochondrial-targeted active Akt protects SH-SY5Y neuroblastoma cells from staurosporine-induced apoptotic cell death
Paramita Mookherjee et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
A tale of two mitochondrial channels, MAC and PTP, in apoptosis
Kathleen W. Kinnally et al.
APOPTOSIS (2007)
Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer:: correlation with clinical or histological findings
Hyun Hoon Chung et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Metabolic catastrophe as a means to cancer cell death
Shengkan Jin et al.
JOURNAL OF CELL SCIENCE (2007)
Role of autophagy in cancer - Management of metabolic stress
Shengkan Jin et al.
AUTOPHAGY (2007)
Furanonaphthoquinones cause apoptosis of cancer cells by inducing the production of reactive oxygen species by the mitochondrial voltage-dependent anion channel
Eriko Simamura et al.
CANCER BIOLOGY & THERAPY (2006)
Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria
S. P. Mathupala et al.
ONCOGENE (2006)
Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis
Kurt Degenhardt et al.
CANCER CELL (2006)
Multiple pathways of cytochrome c release from mitochondria in apoptosis
Vladimir Gogvadze et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2006)
Akt-dependent transformation: there is more to growth than just surviving
DR Plas et al.
ONCOGENE (2005)
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer: a phase II trial of the EORTC-New Drug Development Group
G Giaccone et al.
EUROPEAN JOURNAL OF CANCER (2004)
Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak
N Majewski et al.
MOLECULAR CELL (2004)
Alkylating DNA damage stimulates a regulated form of necrotic cell death
WX Zong et al.
GENES & DEVELOPMENT (2004)
Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases
N Majewski et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Metabolic imaging of tumors using intrinsic and extrinsic fluorescent markers
ZH Zhang et al.
BIOSENSORS & BIOELECTRONICS (2004)
Akt stimulates aerobic glycolysis in cancer cells
RL Elstrom et al.
CANCER RESEARCH (2004)
Alterations in the apoptotic machinery and their potential role in anticancer drug resistance
SH Kaufmann et al.
ONCOGENE (2003)
Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: A Gynecologic Oncology Group Study
L Havrilesky et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis
JG Pastorino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A novel, high conductance channel of mitochondria linked to apoptosis in mammalian cells and Bax expression in yeast
EV Pavlov et al.
JOURNAL OF CELL BIOLOGY (2001)
Bcl-xL promotes the open configuration of the voltage-dependent anion channel and metabolite passage through the outer mitochondrial membrane
MGV Heiden et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53
A Yamaguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study
M De Lena et al.
EUROPEAN JOURNAL OF CANCER (2001)
Bax and Bcl-xL independently regulate apoptotic changes of yeast mitochondria that require VDAC but not adenine nucleotide translocator
S Shimizu et al.
ONCOGENE (2000)
Share Paper
